1. No synergistic effect of extracellular cryoprotectants with dimethyl sulfoxide in the conservation of northern tiger cat fibroblasts.
- Author
-
Silva Viana JVD, Oliveira LRM, Rodrigues LLV, Moura YBF, Pereira ABM, Alves PV, Silva HVR, and Pereira AF
- Abstract
The success of somatic cell cryobanks is dependent on establishing reproducible cryopreservation methodologies. We supposed that associated extracellular cryoprotectants (sucrose and L-proline) with 2.5 or 10% dimethyl sulfoxide (Me
2 SO) could guarantee better northern tiger cat cells quality rates after thawing when compared to Me2 SO alone. Therefore, we evaluated the effects of sucrose or L-proline with 2.5 or 10% Me2 SO on the cryopreservation of northern tiger cat fibroblasts. Somatic cells were also cryopreserved with 2.5% or 10% Me2 SO alone. All cells were analyzed for morphology, membrane integrity, proliferative activity, metabolism, apoptosis classification, reactive oxygen species (ROS) levels, and mitochondrial membrane potential (ΔΨm). Regardless of the cryoprotective solution, cryopreservation did not affect morphology, membrane integrity after culture, proliferative activity, and metabolism (P > 0.05). However, immediately after thawing, 2.5% Me2 SO with L-proline and 10% Me2 SO promoted higher rates of membrane integrity when compared to the other cryopreserved groups (P < 0.05). Interestingly, cells cryopreserved with 10% Me2 SO maintained ROS levels similar to non-cryopreserved cells (P > 0.05). However, the percentage of viable cells evaluated by apoptosis classification was reduced when using 10% Me2 SO with L-proline compared to non-cryopreserved groups (P < 0.05). Additionally, ΔΨm was altered in all cryopreserved groups (P < 0.05). In summary, sucrose and L-proline were less effective in cryopreservation of northern tiger cat fibroblasts in the presence of 2.5% or 10% Me2 SO. Also, 10% Me2 SO appears to be the most suitable cryoprotectant for the formation of cryobanks of this species., Competing Interests: Declaration of Competing Interest The authors declare no conflict of interest., (Copyright © 2024. Published by Elsevier Inc.)- Published
- 2024
- Full Text
- View/download PDF